Literature DB >> 8505474

A T-to-G mutation at nucleotide pair 8993 in mitochondrial DNA in a patient with Leigh's syndrome.

H Yoshinaga1, T Ogino, S Ohtahara, R Sakuta, I Nonaka, S Horai.   

Abstract

We studied a patient with Leigh's syndrome using neurophysiologic, radiologic, enzymatic, biochemical, and molecular analysis. Her clinical course had started with acute encephalopathic symptoms at 7 months of age. With repeated remission and exacerbation, she developed hypotonia and symptoms of brainstem dysfunction, such as irregular respiration and swallowing difficulty. These symptoms were followed by epileptic seizures, including simple partial seizures and tonic spasms. Both serum lactate and serum pyruvate levels were elevated, and deficient activity was detected in cytochrome c oxidase in her quadriceps femoris muscle. From the early stages, we noted an abnormality in the auditory brainstem response and visual evoked potentials, and an abnormal symmetrical low-density area in the basal ganglia on the computed tomographic scan. We found a mitochondrial DNA point mutation at 8993 in blood samples from both the patient and her mother using a simple polymerase chain reaction method. The ratio of wild and mutant mitochondrial DNA calculated densitometrically on polymerase chain reaction products was 56.6% in the patient's blood cells and 8.4% in her mother's. This patient's disorder was thought to be maternally inherited Leigh's syndrome. Her brother had died of the identical clinical features at 1 year 9 months of age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505474     DOI: 10.1177/088307389300800204

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.

Authors:  S L White; S Shanske; J J McGill; H Mountain; M T Geraghty; S DiMauro; H H Dahl; D R Thorburn
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

3.  Intractable Epilepsy in Maternally Inherited Leigh Syndrome (MILS) Due to the Sporadic Variant m.8993T>G in MT-ATP6: A Case Report.

Authors:  Josef Finsterer
Journal:  Cureus       Date:  2022-02-28

Review 4.  Mitochondrial DNA sequence variation in human evolution and disease.

Authors:  D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Frequencies of mtDNA mutations in primary tissues of colorectal adenopolyps.

Authors:  Gregory Adams; Sharifeh Mehrabi; Yupha Vatcharapijarn; Osatohamwen I Iyamu; Joyce A Akwe; William E Grizzle; Xuebiao Yao; Felix O Aikhionbare
Journal:  Front Biosci (Elite Ed)       Date:  2013-06-01

6.  Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families.

Authors:  G Uziel; I Moroni; E Lamantea; G M Fratta; E Ciceri; F Carrara; M Zeviani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

7.  Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  May Yung Tiet; Zhiyuan Lin; Fei Gao; Matthew James Jennings; Rita Horvath
Journal:  J Neuromuscul Dis       Date:  2021
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.